Next Article in Journal
The Relationship between Frontal QRS-T Angle and Vitamin D Deficiency
Previous Article in Journal
Menopausal Hormone Therapy, an Ever-Present Topic: A Pilot Survey about Women’s Experience and Medical Doctors’ Approach
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prediction of Diabetes and Prediabetes among the Saudi Population Using a Non-Invasive Tool (AUSDRISK)

by
Ayoub Ali Alshaikh
1,
Faisal Saeed Al-Qahtani
1,
Hassan Misfer N Taresh
1,
Rand Abdullah A Hayaza
1,
Sultan Saeed M Alqhtani
1,
Sarah Ibrahim Summan
1,
Sultan Abdullah Al Mansour
2,
Omar Hezam A Alsultan
1,
Hassan Yahya M Asiri
1,
Yazeed Mohammed S Alqahtani
1,
Waleed Khaled A Alzailaie
1,
Ahmed Abdullah A Alamoud
1 and
Ramy Mohamed Ghazy
1,3,*
1
Family and Community Medicine Department, College of Medicine, King Khalid University, Abha 61423, Saudi Arabia
2
Asser Center Hospital, Ministry of Health, Abha 62521, Saudi Arabia
3
Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria 61421, Egypt
*
Author to whom correspondence should be addressed.
Medicina 2024, 60(5), 775; https://doi.org/10.3390/medicina60050775
Submission received: 29 March 2024 / Revised: 24 April 2024 / Accepted: 4 May 2024 / Published: 7 May 2024
(This article belongs to the Section Endocrinology)

Abstract

:
Background and Objectives: Screening for type 2 diabetes mellitus (DM2) aims to identify asymptomatic individuals who may be at a higher risk, allowing proactive interventions. The objective of this study was to predict the incidence of DM2 and prediabetes in the Saudi population over the next five years. Materials and Methods: The study was conducted in the Aseer region through August 2023 using a cross-sectional survey for data collection. A multistage stratified random sampling technique was adopted, and data were collected through face-to-face interviews using the validated Arabic version of the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK). Results: In total, 652 individuals were included in the study. Their mean age was 32.0 ± 12.0 years; 53.8% were male, 89.6% were from urban areas, and 55.8% were single. There were statistically significant differences between males and females in AUSDRISK items, including age, history of high blood glucose, use of medications for high blood pressure, smoking, physical activity, and measurements of waist circumference (p < 0.05). Based on AUSDRISK scores, 46.2% of the included participants were predicted to develop impaired glucose tolerance within the coming five years (65.8% among females vs. 23.6%), and 21.9% were predicted to develop DM2 (35.6% among males vs. 6.0% among females); this difference was statistically significant (p = 0.0001). Conclusions: Urgent public health action is required to prevent the increasing epidemic of DM2 in Saudi Arabia.

1. Introduction

The prevalence of diabetes mellitus (DM) is experiencing a significant global increase, especially in the Middle East and North Africa (MENA), owing to factors such as urbanization, aging of the population, and lifestyle changes [1,2]. The International Diabetes Federation (IDF) estimates that 537 million adults aged 20–79 years will have diabetes by 2021, representing approximately one in every ten people. This figure is expected to rise to 643 million by 2030 and then to 783 million by 2045. More than three out of every four people with diabetes live in low- and middle-income countries, highlighting the global burden of this condition in less-prosperous regions [3]. In 2021 alone, DM was responsible for 6.7 million deaths, equivalent to one person losing their life every 5 s due to the disease. The economic burden of diabetes is significant, with health expenditure reaching at least 966 billion USD by 2021. This marks a notable 316% increase over the past 15 years, underscoring the financial strain it imposes on the healthcare system. Furthermore, 541 million adults have impaired glucose tolerance (IGT), a condition that puts them at a high risk of developing type 2 diabetes (DM2) [3].
DM2 accounts for 90–95% of all diagnosed cases of diabetes, while type 1 diabetes accounts for 5–10% [4]. The development and progression of DM2 are influenced by several modifiable and non-modifiable risk factors. Obesity, physical inactivity, poor diet, high blood pressure, and smoking are all possible risk factors. Non-modifiable risk factors, on the other hand, include age, family history, ethnicity, and genetic predisposition [5]. IDF emphasizes lifestyle modifications such as increased physical activity and the adoption of a healthy diet as effective measures to prevent or delay the onset of DM2 [6].
Approximately 73 million people in the MENA region live with DM. In 2021, diabetes affected 17.7% of the total adult population in Saudi Arabia alone, amounting to approximately 4,274,100 cases [7]. A comprehensive epidemiological health study was conducted in Saudi Arabia, focusing on adults aged 30–70 years. Among the 16,917 survey participants, 4004 were diagnosed with DM, representing approximately 23.7% of the population [8]. However, higher prevalence rates of DM have been observed among Saudis, ranging from 26.0% to 61.8% [9,10].
These figures emphasize the importance of effective preventive strategies and enhanced care management to address the country’s increasing DM burden. One of these techniques is DM screening, which attempts to identify asymptomatic patients who may be at risk, thus allowing for preventive therapy [11]. For a long time, DM screening depended on invasive, inconvenient, and costly approaches, such as blood samples for fasting plasma glucose (FPG), the 2-h oral glucose tolerance test (OGTT), or measurements of glycated hemoglobin (HbA1c) [12]. However, researchers in many countries have devised non-invasive risk assessment scoring methods that are more practical, less time-consuming, and cost-effective for detecting DM2 [13]. These risk scores incorporate the most effective behavioral and biological risk factors into a scaled instrument for dual screening and prediction functions. Several risk scores, including the American Diabetes Association Diabetes Risk Test (ADADRT), the Finnish Diabetes Risk Score (FIN-DRISK), the Canadian Diabetes Risk Questionnaire (CANRISK), the German Diabetes Risk Score (GDRS), and the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK), have been developed and used around the world [14,15].
A team of Egyptian researchers translated AUSDRISK into Arabic and assessed its reliability and validity among Egyptians. The recalibrated Arabic AUSDRISK was shown to be a simple, reliable, and valid tool for predicting DM risk, suggesting its use in mass public screening to reduce the disease burden and health costs [16]. Therefore, its use in opportunistic mass public screening is highly recommended, owing to its cost-effectiveness. By employing this screening tool, it is possible to preemptively identify individuals at risk of developing DM2, which can significantly reduce the disease burden and associated health expenditure. With early detection and targeted preventive measures, the burden of DM2 can be mitigated, leading to better health outcomes for the population [17].
The objective of this study was to predict the incidence of DM2 and prediabetes in the Saudi population over the next five years using the valid Arabic version of the AUSDRISK tool. Using AUSDRISK, researchers aimed to gain insight into the future incidence of DM2, thus facilitating the development of effective preventive measures and interventions to address the health challenges posed by DM in Saudi Arabia.

2. Materials and Methods

2.1. Study Setting and Study Duration

This study was conducted in the Aseer region of Saudi Arabia, one of the country’s administrative regions, situated in the southwestern part of Saudi Arabia, with Abha as its capital. This study was conducted in August, 2023.

2.2. Study Design and Sampling Technique

This study used a cross-sectional survey for data collection utilizing a multistage stratified random sampling technique. In the Aseer region, which consists of 17 governorates, three were randomly selected. One health center was randomly included in each selected governorate. The selection of apparently healthy adults visiting these centers was conducted using a systematic random sampling method.

2.3. Sample Size and Study Population

The minimum required sample size, as determined using G*Power software version 3.1, Franz Fuel, Germany, to investigate the prevalence of undiagnosed DM2 among the Saudi population was 318, based on the following assumptions: an expected prevalence of diabetes of 17.7%, sensitivity of AUSDRISK set to 81.3%, specificity set to 57.7%, an alpha error of 0.05, a non-response rate of 5%, and a precision of 10%. The sample size was doubled to compensate for the stratification based on sex. The study included apparently healthy Saudi adults without DM, aged 18 years or older, who resided in the Aseer region.

2.4. Data Collection

Data were collected through face-to-face interviews with respondents. The first section of the questionnaire focused on collecting information on various socioeconomic factors. This included capturing the participants’ age, sex, residence (rural or urban), marital status (divorced, married, single, or widowed), and education (secondary, university, or postgraduate levels). Participants’ monthly income levels were categorized into specific ranges from below 5000 Saudi Riyal (SAR) to above 20,000 SAR, and their occupation was recorded as do not work, governmental sector, private, or retired. Finally, participants were categorized by nationality as Saudi or non-Saudi. Respondents were asked about associated comorbidities, such as hypertension, thyroid issues, renal disease, liver disease, ischemic heart disease, chronic obstructive airway disease, cerebrovascular disease, and autoimmune disease. The second section included the validated Arabic version of the AUSDRISK tool [18], which assesses nine risk factors: age, sex, family history of diabetes, history of high blood glucose, hypertension, smoking, fruit and vegetable intake, physical activity, and waist circumference (Table 1). The sensitivity and specificity of the Arabic version of AUSDRISK at a cut-off point of 13 were 86.11% and 73.35%, respectively, with a 0.887 (95% confidence interval (CI): 0.824–0.95) area under the curve (AUC), p < 0.001. Sensitivity and specificity for the detection of abnormal hyperglycemia levels were at a cut-off point of 9 with an AUC of 0.767 (CI: 0.727–0.807), p < 0.001 [18].
Anthropometric measurements: To measure waist circumference, assessors gently surrounded the waist of the respondent with measuring tape, positioning it at the level of the top of the hip bone. At a relatively large waist circumference (102 cm for men and 88 cm for women), specific cutoff points have been established to identify risk. Ensure that the tape runs parallel to the ground and forms a complete circle around the trunk. Body mass index (BMI) was calculated using the following formula: BMI = weight (kg)/height (m)2. To calculate BMI, the body weight in kilograms was divided by the height squared in meters. The BMI categories were as follows: BMI below 18.5 is classified as underweight, while BMI ranging from 18.5 to less than 25 was considered within the healthy weight range. A BMI between 25.0 and less than 30 indicates that the individual is overweight, and a BMI of 30.0 or higher denotes obesity [19].

2.5. Study Outcome

The primary objective of this study was to determine the expected incidence of diabetes and prediabetes among apparently healthy adults over the next five years. In addition, this study aimed to identify the determinants associated with these conditions.

2.6. Ethical Consideration

Ethical approval was obtained from the Ethics Committee of the King Khalid University, Abha, Saudi Arabia (ECM # 2023-401). To ensure ethical conduct, all participants provided written informed consent before participation. The study strictly adhered to the ethical guidelines of the Declaration of Helsinki, ensuring the protection of the rights, safety, and confidentiality of participants, while upholding the highest ethical standards in research.

2.7. Statistical Analysis

Data were analyzed using R software version 4.2. Numerical variables were summarized using the mean and standard deviation. In cases where the data exhibited skewness, the median and interquartile range (IQR) were used. Categorical variables were presented as numbers and percentages. The association between the outcome and different categorical variables was assessed using the chi-square test. The Mann–Whitney U test was used to compare non-normally distributed numerical variables. The significance level (p value) for all statistical tests was set at 0.05, indicating statistical significance at p < 0.05.

3. Results

Table 2 describes the demographic and socioeconomic variables of the 652 individuals studied. The mean age of the participants was 32 ± 12 years, ranging 18.0–92.0 years; 53.8% of the studied participants were male, 89.6% were from urban areas, and approximately three-fifths of the participants were single (55.8%), followed by married (39.6%). Regarding education, 23.0% attained secondary, 67.2% university, and 7.5% postgraduate degrees. The largest group in terms of earnings was below 5000 SAR (41.0%), followed by 5000–10,000 SAR (30.2%). Nearly two-fifths of the participants (38.7%) were unemployed, followed by those working in the government sector (36.5%), with 19.5% working in the private sector. The majority of the participants were Saudi (92.9%), with a smaller percentage being non-Saudi (7.1%).
The mean BMI was 26.0 ± 8.80 (range 16.0–22.0). Hypertension was reported in 5.7% of the participants, while thyroid disease was reported in 2.9%. The prevalence rates of renal and liver diseases, ischemic heart disease, chronic obstructive airway disease, cerebrovascular disease, and autoimmune diseases range from 0.2% to 1.8%. A significant proportion of participants (49.2 %) reported a family history of DM (Table 3).
Table 4 shows that there were statistical differences between men and women in AUSDRISK items, including age (χ2 = 21.96, p = 0.001), previous history of high blood glucose (sugar) (χ2 = 7.527, p = 0.006), taking medication for high blood pressure, which was also significant across gender (χ2 = 16.178, p = 0.0001), smoking (χ2 = 139.371, p = 0.0001), physical activity [χ2 = 12.06, p = 0.001], and waist circumference (χ2 = 27.002, p = 0.0001).
Figure 1 shows that 21.9% (143) will develop diabetes, 35.6% among males vs. 6.0% among females (χ2 = 81.38, p = 0.0001). Similarly, 46.30% (302) of the participants will develop impaired glucose tolerance in the next five years as they scored 9 or more on AUSDRISK (65.8% among women vs. 23.6% among men); this difference was statistically significant (χ2 = 114.50, p = 0.0001) (Figure 2).
Several sociodemographic factors were associated with an AUSDRISK score of 13 or higher, including marital status, education, income, residence, and occupation. Married participants had a higher AUSDRISK score than single participants (66.4% vs. 32.0%; p < 0.001). Regarding educational level, 72.7% of those with AUSDRISK < 13 had a university degree, compared to 53.8% of those with AUSDRISK ≥ 13 (p < 0.001). According to the results, 45.4% of individuals with an AUSDRISK score of less than 13 had a monthly income of less than 5000 SAR, compared to only 25.2% of those with an AUSDRISK score greater than or equal to 13. This difference was statistically significant (p < 0.001). Significant differences were also observed between residences and occupations. There was also a significant association between having chronic diseases, like ischemic heart disease and hyperlipidemia, and a high AUSDRISK (Table 5).

4. Discussion

DM2 is a metabolic disorder characterized by insulin resistance and pancreatic β-cell dysfunction. The role of inflammation in insulin resistance can be traced to the integration of metabolism and innate immunity via nutrient-sensing pathways that are mutually related to pathogen-sensing pathways [20,21].

The Main Findings of the Study

In this study, we aimed to predict the incidence of prediabetes and DM2 among the apparently healthy Saudi population in the Aseer region using the validated noninvasive Arabic version of AUSDRISK. Interestingly, more than two-fifths of the participants were predicted to develop either prediabetes or DM2 in the coming five years. The AUSDRISK score was higher among males than among females, with a higher prevalence of undiagnosed hyperglycemia. Several factors were associated with undiagnosed hyperglycemia, including marital status, educational level, income, residence, occupation, ischemic heart disease, and hyperlipidemia.
Tools to predict the incidence of diabetes: Various risk models, commonly referred to as risk scores, have been developed to identify cases of DM2. Although some are effective in detecting undiagnosed (prevalent) DM2 cases [22], others predict the onset of new (incident) DM2 cases, including the Finnish Diabetes Risk Score (FINDRISC) [23], Peruvian Risk Score [24], and AUSDRISK. In this study, we used the AUSDRISK tool to predict the incidence of DM2 in the Saudi population. AUSDRISK proved to be a straightforward, cost-effective, and efficient approach to assess diabetes risk compared to blood glucose testing [25]. Ten different medical, lifestyle, and demographic factors were incorporated into the AUSDRISK tool, which was created for use within an Australian community to predict the 5-year risk of DM2. The Australian Government Department of Health and Aging established the AUSDRISK tool in July 2008, and qualified patients can receive Medicare reimbursements [15]. In this study, we used the validated Arabic version, which consists of nine questions. The ethnicity question was omitted during the validation process. However, the tool still shows high performance in the prediction of DM2 incidence.
Predicted incidence of diabetes and prediabetes: The frequency of diabetes has increased rapidly in Saudi Arabia, from 7% in 1989 to 32% in 2009 [26]. Moreover, the prevalence of undiagnosed DM2 is high; nearly one-third (36.1%) of the apparently healthy population in Alqunfudah, Saudi Arabia, was diagnosed with DM2, and 28.3% had impaired fasting glucose [27]. Interestingly, in this study, we predicted that 46.2% will develop impaired glucose tolerance within the next five years since they scored above 9 on UDSRISK, and 21.9% will develop DM2 because they scored 13 or above on AUDRISK. Our findings support a previous study that predicted that the prevalence of DM2 in Saudi Arabia would increase from 32.8% in 2015 to 45.36% in 2030 [28]. These findings indicate an alarmingly high incidence of DM, as well as a change in the prevalence of DM over time. According to the IDF, the prevalence of diabetes in Saudi Arabia is among the top ten countries among people aged 20–79 [29]. The high prevalence of DM highlights the urgent need to adopt novel public health strategies to effectively manage this disease in Saudi Arabia. These strategies may include community-based screening programs [27,30] and focused interventions aimed at increasing public awareness of diabetes mellitus and its consequences [31].
Factors associated with the development of diabetes: We found that males were more likely to have DM2 than females, and the same was true for impaired glucose levels. Several studies conducted in Saudi Arabia have found a higher frequency of DM in males [8,32]. The high prevalence of obesity among males may be attributed to unhealthy dietary habits [33] that result in an increased risk of obesity [34].
We found that the adoption of healthier lifestyles in the form of physical activity and non-smoking was more common among women than among men. According to the 2014 Surgeon General’s Report, active smokers face a 30–40% higher risk of DM2 than non-smokers [35]. In addition, smoking can exacerbate the challenges associated with managing diabetes and regulating insulin levels. Nicotine diminishes the effectiveness of insulin, necessitating that smokers rely on increased insulin doses to stabilize their blood sugar levels [36]. This underscores the importance of emphasizing smoking cessation as a crucial public health strategy for controlling diabetes worldwide.
Elevated BMI and decreased physical activity were both independently associated with an increased risk of developing DM. Obese people had a nine-fold higher risk than normal-weight people. Physically active individuals had almost two-thirds of the risk of diabetes compared to those who were inactive. Obese and sedentary men had a 17-fold increased risk of diabetes when BMI and physical activity were combined [37].
Several sociodemographic factors were associated with higher AUSDRISK scores, including education, income, residence, occupation, and hyperlipidemia. Similarly, a study conducted in the Eastern Province between 2004 and 2005 found some sociodemographic factors associated with an increased prevalence of DM2. Being widowed (39.1%), unemployed (31.9%), and uneducated (32.3%) was associated with the development of DM2 [38]. Another study conducted by Al-Zahrani and Aldiab [39] found that being older, married, obese, a smoker, or less educated significantly increased the risk for both prediabetes and diabetes.
Implications of this study: This study highlights the sex disparities regarding risk factors associated with DM2, such as smoking, physical activity, and waist circumference, emphasizing the need for tailored prevention strategies. This study also predicts future DM2 and prediabetes based on the AUSDRISK scores and highlights the feasibility of this risk assessment tool. This research further explains the complex interplay of factors that influence diabetes risk, including associations between AUSDRISK scores and sociodemographic factors such as marital status, education, income, residence, occupation, and chronic diseases. Overall, this study underscores the necessity for holistic approaches to diabetes prevention and management, considering diverse sociodemographic and health-related factors.
Strengths and limitations: To our knowledge, this is the first study conducted in Saudi Arabia using a non-invasive tool to predict the incidence of diabetes. Second, we used a multistage stratified random sampling technique to obtain a representative sample from the Aseer region, considering the demographic variations in different governorates. Finally, a validated questionnaire was used to strengthen the internal validity of the study. However, the study used a cross-sectional design, which limits its ability to establish causal relationships between risk factors and the development of DM2 or prediabetes. Despite the stratified sampling technique, there may still be some degree of sampling bias, as participation in the study was based on individuals visiting health centers. This may not capture the experiences of those who do not seek healthcare services. The study relied on self-reported data, which can be subject to recall or social desirability bias, where participants may provide answers that they perceive as more socially acceptable. This study was limited to the Aseer Region of Saudi Arabia. These findings may not be fully representative of the entire Saudi population, which exhibits regional variations in lifestyle and health. Finally, in this study, we did not focus on certain risk factors for the development of DM2, such as stress and dietary habits. Future studies should assess the value of incorporating these factors into the AUSDRISK tool to increase its diagnostic performance.

5. Conclusions

These findings indicate that a substantial proportion of the population studied is at risk of developing impaired glucose tolerance and DM2 within the next five years. These risks are significantly higher among men than among women. These findings underscore the urgent need for targeted public health interventions to address the escalating diabetes epidemic in Saudi Arabia. Healthcare authorities and policymakers must prioritize comprehensive diabetes prevention and management strategies, focusing on risk assessment, lifestyle modifications, health education, and access to healthcare services, particularly for high-risk groups. Early detection and proactive interventions are critical to mitigate the potential health and economic burdens associated with diabetes in the Saudi population.

Author Contributions

Conceptualization, R.M.G. and A.A.A.; methodology, R.M.G. and F.S.A.-Q.; software, H.M.N.T.; validation, R.A.A.H., S.S.M.A. and S.I.S.; formal analysis, R.M.G. and S.A.A.M. investigation, O.H.A.A.; resources, H.Y.M.A.; data curation, A.A.A.A.; writing—original draft preparation, Y.M.S.A., A.A.A. and R.M.G.; writing—review and editing, R.M.G. and W.K.A.A.; visualization, Y.M.S.A.; supervision, A.A.A.; project administration, A.A.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical approval was obtained from the Research Ethics Committee at King Khalid University, Abha, Saudi Arabia (ECM # 2023-401, Approval date 17 August 2023). The study was conducted in accordance with the Declaration of Helsinki.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data are available upon request upon emailing the corresponding author.

Acknowledgments

We would like to acknowledge the study participants who participated in this study. The authors extends their appreciation to the Deanship of Research and Graduates studies at King Khalid University for funding this work through small under grant number group research RGP1/180/45.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Yan, Y.; Wu, T.; Zhang, M.; Li, C.; Liu, Q.; Li, F. Prevalence, awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population. BMC Public Health 2022, 22, 1382. [Google Scholar] [CrossRef] [PubMed]
  2. Atlas, D. International diabetes federation. In IDF Diabetes Atlas, 7th ed.; International Diabetes Federation: Brussels, Belgium, 2015; Volume 33. [Google Scholar]
  3. Sun, H.; Saeedi, P.; Karuranga, S.; Pinkepank, M.; Ogurtsova, K.; Duncan, B.B.; Stein, C.; Basit, A.; Chan, J.C.; Mbanya, J.C. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022, 183, 109119. [Google Scholar] [CrossRef] [PubMed]
  4. Centers for Disease Control and Prevention. Diabetes Fast Facts. Available online: https://www.cdc.gov/diabetes/basics/quick-facts.html (accessed on 22 September 2023).
  5. Galicia-Garcia, U.; Benito-Vicente, A.; Jebari, S.; Larrea-Sebal, A.; Siddiqi, H.; Uribe, K.B.; Ostolaza, H.; Martín, C. Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci. 2020, 21, 6275. [Google Scholar] [CrossRef]
  6. Davies, M.J.; Aroda, V.R.; Collins, B.S.; Gabbay, R.A.; Green, J.; Maruthur, N.M.; Rosas, S.E.; Del Prato, S.; Mathieu, C.; Mingrone, G.; et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2022, 45, 2753–2786. [Google Scholar] [CrossRef] [PubMed]
  7. International Diabetes Federation. Diabetes in Saudi Arabia. 2021. Available online: https://idf.org/our-network/regions-and-members/middle-east-and-north-africa/members/saudi-arabia/ (accessed on 22 September 2023).
  8. Alqurashi, K.A.; Aljabri, K.S.; Bokhari, S.A. Prevalence of diabetes mellitus in a Saudi community. Ann. Saudi Med. 2011, 31, 19–23. [Google Scholar] [CrossRef]
  9. Al-Hariri, M.T.; Al-Enazi, A.S.; Alshammari, D.M.; Bahamdan, A.S.; Al-Khtani, S.M.; Al-Abdulwahab, A.A. Descriptive study on the knowledge, attitudes and practices regarding the diabetic foot. J. Taibah Univ. Med. Sci. 2017, 12, 492–496. [Google Scholar] [CrossRef] [PubMed]
  10. Goweda, R.; Shatla, M.; Alzaidi, A.; Alzaidi, A.; Aldhawani, B.; Alharbi, H.; Sultan, N.; Alnemari, D.; Rawa, B. Assessment of knowledge and practices of diabetic patients regarding diabetic foot care, in Makkah, Saudi Arabia. J. Fam. Med. Health Care 2017, 3, 17. [Google Scholar] [CrossRef]
  11. Peer, N.; Balakrishna, Y.; Durao, S. Screening for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2020, 5, Cd005266. [Google Scholar] [PubMed]
  12. Ortiz-Martínez, M.; González-González, M.; Martagón, A.J.; Hlavinka, V.; Willson, R.C.; Rito-Palomares, M. Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus. Curr. Diabetes Rep. 2022, 22, 95–115. [Google Scholar] [CrossRef]
  13. Woo, Y.C.; Gao, B.; Lee, C.H.; Fong, C.H.; Lui, D.T.; Ming, J.; Wang, L.; Yeung, K.M.; Cheung, B.M.; Lam, T.H.; et al. Three-component non-invasive risk score for undiagnosed diabetes in Chinese people: Development, validation and longitudinal evaluation. J. Diabetes Investig. 2020, 11, 341–348. [Google Scholar] [CrossRef]
  14. Abdallah, M.; Sharbaji, S.; Sharbaji, M.; Daher, Z.; Faour, T.; Mansour, Z.; Hneino, M. Diagnostic accuracy of the Finnish Diabetes Risk Score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University. Diabetol. Metab. Syndr. 2020, 12, 84. [Google Scholar] [CrossRef] [PubMed]
  15. Chen, L.; Magliano, D.J.; Balkau, B.; Colagiuri, S.; Zimmet, P.Z.; Tonkin, A.M.; Mitchell, P.; Phillips, P.J.; Shaw, J.E. AUSDRISK: An Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med. J. Aust. 2010, 192, 197–202. [Google Scholar] [CrossRef]
  16. Farag, H.F.M.; Sultan, E.A.; Elrewany, E.; Abdel-Aziz, B.F. Arabic version of the Australian type 2 diabetes risk assessment tool (AUSDRISK): Translation and validation. BMC Res. Notes 2022, 15, 303. [Google Scholar] [CrossRef] [PubMed]
  17. Charokopou, M.; Sabater, F.; Townsend, R.; Roudaut, M.; McEwan, P.; Verheggen, B. Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in Health Technology Assessments: A systematic review of the literature from 2008 to 2013. Curr. Med. Res. Opin. 2016, 32, 207–218. [Google Scholar] [CrossRef]
  18. Farag, H.F.M.; Elrewany, E.; Abdel-Aziz, B.F.; Sultan, E.A. Prevalence and predictors of undiagnosed type 2 diabetes and pre-diabetes among adult Egyptians: A community-based survey. BMC Public Health 2023, 23, 949. [Google Scholar] [CrossRef]
  19. Zierle-Ghosh, A.; Jan, A. Physiology, Body Mass Index; StatPearls Publishing: Treasure Island, FL, USA, 2018. [Google Scholar]
  20. Alqahtani, S.A.M.; Alsaleem, M.A.; Ghazy, R.M. Association between serum ferritin level and lipid profile among diabetic patients: A retrospective cohort study. Medicine 2024, 103, e37631. [Google Scholar] [CrossRef] [PubMed]
  21. Hameed, I.; Masoodi, S.R.; Mir, S.A.; Nabi, M.; Ghazanfar, K.; Ganai, B.A. Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. World J. Diabetes 2015, 6, 598–612. [Google Scholar] [CrossRef]
  22. Noble, D.; Mathur, R.; Dent, T.; Meads, C.; Greenhalgh, T. Risk models and scores for type 2 diabetes: Systematic review. BMJ 2011, 343, d7163. [Google Scholar] [CrossRef]
  23. Bernabe-Ortiz, A.; Perel, P.; Miranda, J.J.; Smeeth, L. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population. Prim. Care Diabetes 2018, 12, 517–525. [Google Scholar] [CrossRef]
  24. Bernabe-Ortiz, A.; Smeeth, L.; Gilman, R.H.; Sanchez-Abanto, J.R.; Checkley, W.; Miranda, J.J.; Study Group, C.C. Development and Validation of a Simple Risk Score for Undiagnosed Type 2 Diabetes in a Resource-Constrained Setting. J. Diabetes Res. 2016, 2016, 8790235. [Google Scholar] [CrossRef]
  25. Kilkenny, M.F.; Johnson, R.; Andrew, N.E.; Purvis, T.; Hicks, A.; Colagiuri, S.; Cadilhac, D.A. Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia. BMC Public Health 2014, 14, 1227. [Google Scholar] [CrossRef] [PubMed]
  26. Alharbi, N.S.; Almutari, R.; Jones, S.; Al-Daghri, N.; Khunti, K.; De Lusignan, S. Trends in the prevalence of type 2 diabetes mellitus and obesity in the Arabian Gulf States: Systematic review and meta-analysis. Diabetes Res. Clin. Pract. 2014, 106, e30–e33. [Google Scholar] [CrossRef] [PubMed]
  27. Alshaikhi, S.A.; Alamri, A.M.; Alzilai, I.Y.; Alghanimi, A.A.; Alrufaidi, A.M.; Alrufaidi, A.M.; Bader, A.E.; Abdelmoniem, A.A.; Alshaikh, A.A.; Alshaikhi, O.A.; et al. Diabetes and prediabetes prevalence through a community-based screening initiative in Alqunfudah, Saudi Arabia. Future Sci. OA 2024, 10, FSO946. [Google Scholar] [CrossRef]
  28. Meo, S.A. Prevalence and future prediction of type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A systematic review of published studies. J. Pak. Med. Assoc. 2016, 66, 722–725. [Google Scholar]
  29. Boutayeb, A.; Boutayeb, W.; Lamlili, M.E.; Boutayeb, S. Estimation of the direct cost of diabetes in the Arab region. Mediterr. J. Nutr. Metab. 2014, 7, 21–32. [Google Scholar] [CrossRef]
  30. Farag Mohamed, H.; Allam, M.M.; Hamdy, N.A.; Ghazy, R.M.; Emara, R.H. A Community Pharmacy-Based Intervention in the Matrix of Type 2 Diabetes Mellitus Outcomes (CPBI-T2DM): A Cluster Randomized Controlled Trial. Clin. Med. Insights Endocrinol. Diabetes 2021, 14, 11795514211056307. [Google Scholar] [CrossRef]
  31. Alshaikh, A.A.; Alqarni, H.M.; Assiri, H.A.H.; Shlwan, M.A.; AlJebreel, M.A.; Almuaddi, A.S.; Asiri, M.A.; Almuidh, F.N.A.; Al Qasim, N.Y.; Alshahrani, O.A. Knowledge, Attitude, and Practice of Diabetic Foot Ulcer Care in Asser Region: A Cross-Sectional Study. Cureus 2023, 15, e42807. [Google Scholar] [CrossRef]
  32. Alqahtani, B.; Elnaggar, R.K.; Alshehri, M.M.; Khunti, K.; Alenazi, A. National and regional prevalence rates of diabetes in Saudi Arabia: Analysis of national survey data. Int. J. Diabetes Dev. Ctries. 2023, 43, 392–397. [Google Scholar] [CrossRef]
  33. Mahfouz, A.A.; Alsaleem, S.A.; Alsaleem, M.A.; Ghazy, R.M. Prevalence of Obesity and Associated Dietary Habits among Medical Students at King Khalid University, Southwestern Saudi Arabia. Medicina 2024, 60, 347. [Google Scholar] [CrossRef]
  34. Alshaikh, A.A.; Alqahtani, A.S.; AlShehri, F.A.; Al Hadi, A.M.; Alqahtani, M.M.M.; Alshahrani, O.M.; Albraik, M.A.; Alamri, S.A.; Ghazy, R.M.; Alshahrani, O.M., Jr. Examining the Impact of Socioeconomic Factors and Lifestyle Habits on Obesity Prevalence Among Male and Female Adolescent Students in Asser, Saudi Arabia. Cureus 2023, 15, e43918. [Google Scholar] [CrossRef]
  35. Lushniak, B.D.; Samet, J.M.; Pechacek, T.F.; Norman, L.A.; Taylor, P.A. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General; US Department of Health and Human Services, Centers for Disease: Atlanta, GA, USA, 2014. [Google Scholar]
  36. Cai, X.; Chen, Y.; Yang, W.; Gao, X.; Han, X.; Ji, L. The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: A meta-analysis. Endocrine 2018, 62, 299–306. [Google Scholar] [CrossRef] [PubMed]
  37. Kirsti Vik, H.; Jo, S.S.; Tom, I.L.N. Adiposity, physical activity and risk of diabetes mellitus: Prospective data from the population-based HUNT study, Norway. BMJ Open 2017, 7, e013142. [Google Scholar]
  38. Al-Baghli, N.A.; Al-Ghamdi, A.; Al-Turki, K.; Al Elq, A.; El-Zubaier, A.; Bahnassy, A. Prevalence of diabetes mellitus and impaired fasting glucose levels in the Eastern Province of Saudi Arabia: Results of a screening campaign. Singap. Med. J. 2010, 51, 923. [Google Scholar]
  39. Al-Zahrani, J.M.; Aldiab, A.; Aldossari, K.K.; Al-Ghamdi, S.; Batais, M.A.; Javad, S.; Nooruddin, S.; Zahid, N.; Razzak, H.A.; El-Metwally, A. Prevalence of Prediabetes, Diabetes and Its Predictors among Females in Alkharj, Saudi Arabia: A Cross-Sectional Study. Ann. Glob. Health 2019, 85, 109. [Google Scholar] [CrossRef]
Figure 1. Risk of developing diabetes mellitus in the coming five years among all study participants and between males and females.
Figure 1. Risk of developing diabetes mellitus in the coming five years among all study participants and between males and females.
Medicina 60 00775 g001
Figure 2. The risk of developing impaired glucose tolerance in the coming five years among all study participants and between males and females.
Figure 2. The risk of developing impaired glucose tolerance in the coming five years among all study participants and between males and females.
Medicina 60 00775 g002
Table 1. Items of the validated Arabic version of AUSDRISK.
Table 1. Items of the validated Arabic version of AUSDRISK.
Question Points
1Age
Less than 35 years 0
35–44 years 2
45–54 years 4
55–64 years 6
65 years or older 8
2Gender
Female 0
Male 3
3Has either of your parents or siblings been diagnosed with diabetes (type 1 or type 2)?
No 0
Yes 3
4Have you ever had high blood sugar levels (e.g., during a health checkup, illness, or pregnancy)?
No 0
Yes 6
5Currently, are you taking medication for high blood pressure?
No 0
Yes 2
6Currently, do you smoke cigarettes or any other tobacco product daily?
No 0
Yes 2
7Typically, how often do you consume vegetables or fruits?
Every day 0
Not every day 1
8On average, do you believe you engage in physical activity for at least 2.5 h per week (e.g., 30 min daily for 5 days or more per week)?
Yes 0
No 2
9Waist measurement at the bottom of the ribs (usually at the level of the navel and while standing):
Waist measurement (cm)
MenWomen
Less than 102 cmLess than 88 cm0
102–110 cm88–100 cm4
More than 110 cmMore than 100 cm7
Table 2. Sociodemographic characteristics of the study population.
Table 2. Sociodemographic characteristics of the study population.
Studied VariablesOverall (N = 652)
AgeMean (SD)32.0 ± 12.0
Median [Min, Max]28 [14, 92]
SexFemale301 (46.2%)
Male351 (53.8%)
ResidenceRural68 (10.4%)
Urban584 (89.6%)
Marital statusDivorced24 (3.7%)
Married258 (39.6%)
Single364 (55.8%)
Widow6 (0.9%)
EducationSecondary150 (23.0%)
University453 (67.2%)
Postgraduate49 (7.5%)
Below 5000 SAR267 (41.0%)
Income (month)5000–10,000 SAR 197 (30.2%)
10,000–15,000 SAR104 (16.0%)
15,000–20,000 SAR55 (8.4%)
More than 20,000 SAR 29 (4.4%)
OccupationDo not work252 (38.7%)
Governmental sector238 (36.5%)
Private127 (19.5%)
Retired35 (5.4%)
NationalityNon-Saudi46 (7.1%)
Saudi606 (92.9%)
Table 3. Medical history of study population.
Table 3. Medical history of study population.
Studied VariablesMean (SD)
Body mass indexMedian [Min, Max]26.0 [16.0, 22.0]
Hypertension37 (5.7%)
Thyroid 19 (2.9%)
Renal 4 (0.6%)
Hepatic disease1 (0.2%)
Ischemic heart disease12 (1.8%)
Chronic obstructive airway disease 6 (0.9%)
Cerebrovascular disease10 (1.5%)
Autoimmune disease6 (0.9%)
Family history of diabetes mellitus325 (49.2%)
Table 4. Differences in AUSDRISK by gender.
Table 4. Differences in AUSDRISK by gender.
Items
(N = 652)
PointsOverallFemaleMaleTest Statistics
N%N%
Age below 35 years0426 (65.3%)22374.120357.8χ2 = 21.963, p = 0.001
35–44 years2129 (19.8%)5116.97822.2
45–54 years464 (9.8%)1864613.1
55–64 years629 (4.4%)82.7216
≥65 years84 (0.6%)10.330.9
Have you ever been found to have high blood glucose (sugar) No0579 (88.8%)27390.730687.2χ2 = 1.68, p = 0.195
Yes673 (11.2%)289.34512.8
Have either of your parents or any of your brothers or sisters been diagnosed with diabetesNo0325 (49.8%)15752.215744.7χ2 = 7.527, p = 0.006
Yes3327(50.2%)19464.519455.3
Are you currently taking medication for high blood pressure?No0611 (93.7%)2959831690χ2 = 16.18, p = 0.0001
Yes341 (6.3%)623510
Do you currently smoke cigarettes or any other tobacco products daily?No0485 (74.4%)29096.319555.6χ2 = 139.37, p = 0.0001
Yes2167 (25.6%)113.715644.4
How often do you eat vegetables or fruits?No0138 (21.2%)5819.38022.8χ2 = 1.003, p = 0.316
Yes2514 (78.8%)24380.727177.2
On average, would you say you do at least 2.5 h of physical activity per week?No0311 (47.7%)12140.219054.1χ2 = 12.06, p = 0.001
Yes2341 (52.3%)18059.816145.9
Waist circumferenceMale < 102 cm/female < 88 cm0509 (78.1%)26086.424970.9χ2 = 27.00, p = 0.0001
Male 102–110 cm/female 88–100 cm483 (12.7%)30105315.1
Male > 110 cm/female > 100760 (9.2%)113.74914
Total score 8.0 (5.0–31.0)10.0 (7.0–16.0)9(7.0–14.0)W = 16,294, p < 0.001
Table 5. Factors associated with higher AUSDRISK scores.
Table 5. Factors associated with higher AUSDRISK scores.
Dependent: Undiagnosed AUSRISK ≥ 13AUSDRISK < 13p
Marital statusDivorced8 (5.6)16 (3.1)<0.001
Married95 (66.4)163 (32.0)
Single37 (25.9)327 (64.2)
Widow3 (2.1)3 (0.6)
Illiterate0 (0.0)5 (1.0)
EducationPrimary1 (0.7)0 (0.0)<0.001
Secondary50 (35.0)100 (19.6)
University77 (53.8)370 (72.7)
Postgraduate15 (10.5)34 (6.7)
IncomeBelow 5000 SAR36 (25.2)231 (45.4)<0.001
5000–10,000 SAR41 (28.7)156 (30.6)
10,000–15,000 SAR31 (21.7)73 (14.3)
15,000–20,000 SAR19 (13.3)36 (7.1)
20,000 SAR16 (11.2)13 (2.6)
ResidenceRural26 (18.2)42 (8.3)0.001
Urban117 (81.8)467 (91.7)
OccupationDo not work26 (18.2)226 (44.4)<0.001
Governmental sector59 (41.3)179 (35.2)
Private32 (22.4)95 (18.7)
Retired26 (18.2)9 (1.8)
NationalityNon-Saudi11 (7.7)35 (6.9)0.879
Saudi132 (92.3)474 (93.1)
Ischemic heart diseaseNo134 (93.7)506 (99.4)<0.001
Yes9 (6.3)3 (0.6)
HyperlipidemiaMaybe45 (31.5)66 (13.0)<0.001
No78 (54.5)417 (81.9)
Yes20 (14.0)26 (5.1)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alshaikh, A.A.; Al-Qahtani, F.S.; Taresh, H.M.N.; Hayaza, R.A.A.; Alqhtani, S.S.M.; Summan, S.I.; Al Mansour, S.A.; Alsultan, O.H.A.; Asiri, H.Y.M.; Alqahtani, Y.M.S.; et al. Prediction of Diabetes and Prediabetes among the Saudi Population Using a Non-Invasive Tool (AUSDRISK). Medicina 2024, 60, 775. https://doi.org/10.3390/medicina60050775

AMA Style

Alshaikh AA, Al-Qahtani FS, Taresh HMN, Hayaza RAA, Alqhtani SSM, Summan SI, Al Mansour SA, Alsultan OHA, Asiri HYM, Alqahtani YMS, et al. Prediction of Diabetes and Prediabetes among the Saudi Population Using a Non-Invasive Tool (AUSDRISK). Medicina. 2024; 60(5):775. https://doi.org/10.3390/medicina60050775

Chicago/Turabian Style

Alshaikh, Ayoub Ali, Faisal Saeed Al-Qahtani, Hassan Misfer N Taresh, Rand Abdullah A Hayaza, Sultan Saeed M Alqhtani, Sarah Ibrahim Summan, Sultan Abdullah Al Mansour, Omar Hezam A Alsultan, Hassan Yahya M Asiri, Yazeed Mohammed S Alqahtani, and et al. 2024. "Prediction of Diabetes and Prediabetes among the Saudi Population Using a Non-Invasive Tool (AUSDRISK)" Medicina 60, no. 5: 775. https://doi.org/10.3390/medicina60050775

Article Metrics

Back to TopTop